No profile data available.
Pacira BioSciences, Inc. (PCRX) is a healthcare company in the sedation pharmaceuticals industry, based in Brisbane, United States, with about 825 full-time employees.
It reported revenue of $726.41 million for fiscal year 2025, up 3.6% from fiscal year 2024, and net income of $7.03 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $177.38 million, up 5.0% from a year before. Its market capitalization was $1.45 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.
Pacira BioSciences reported $726.41 million in revenue for fiscal year 2025, up 3.6% from $700.97 million in fiscal year 2024. In Q1 2026 revenue was $177.38 million.
$1.45 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (sedation pharmaceuticals) include Scilex Holding Company (SCLX), PRF Technologies Ltd. (PRFX).